Daily Cosmetic Research Analysis
Analyzed 33 papers and selected 3 impactful papers.
Summary
Three papers advance cosmetic and dermatologic science from bench to policy. A CRISPR-engineered zebrafish platform produced human type III collagen with superior stability and accelerated murine wound healing. High-resolution non-target screening revealed widespread organic chlorinated chemicals, including banned substances, in children’s skincare, while an oat extract was shown to inhibit MRGPRX2-driven mast cell activation, suggesting anti-itch potential.
Research Themes
- Translational biomaterials for wound healing and anti-aging
- Analytical toxicology and regulatory surveillance of cosmetics
- Natural product modulation of skin immuno-neurosensory pathways
Selected Articles
1. CRISPR-engineered zebrafish expression system for human type III collagen: Therapeutic efficacy in wound healing.
Using CRISPR/Cas9, the authors created a transgenic zebrafish platform producing human type III collagen with intact fibrillar structure and high thermostability. The resulting collagen composite enhanced fibroblast proliferation, reduced inflammatory cytokines, and achieved >95% wound closure in mice within 15 days, highlighting translational potential for wound dressings and anti-aging skin therapies.
Impact: This work introduces a novel, scalable platform to produce functionally intact human type III collagen with superior stability and demonstrated in vivo efficacy. It bridges biomaterials engineering with therapeutic dermatology, enabling next-step translational studies.
Clinical Implications: If safety and immunogenicity profiles are favorable, this collagen source could underpin next-generation wound dressings and dermal fillers or scaffolds for skin rejuvenation. Standardization and GMP-scale production will be critical for clinical translation.
Key Findings
- CRISPR/Cas9 integration of human Col3a1 into zebrafish chromosome 4 yielded a collagen composite (Col III-TC) with 45.76% extraction yield.
- The material showed intact fibrous architecture and a thermal shrinkage temperature of 71.3 °C, outperforming conventional systems.
- In vitro, Col III-TC reduced LPS-induced Tnfα, Il1b, and Il6 and increased Il10, while promoting fibroblast proliferation.
- In a murine acute wound model, Col III-TC dressings achieved >95% closure within 15 days with improved neoskin thickness and collagen deposition.
Methodological Strengths
- Precise genome engineering and structural validation of the collagen product
- Multiscale evaluation across biochemical assays, cell biology, and an in vivo wound model
Limitations
- Preclinical study without human clinical data; sample size details not specified
- Composite of human and fish collagens may pose immunogenicity/regulatory challenges
Future Directions: Undertake comprehensive toxicology and immunogenicity studies, GMP-scale production, and head-to-head comparisons with bovine/porcine collagens, followed by early-phase clinical trials in wound care and dermal regeneration.
Human type III collagen (Col III) is a critical component for skin tissue repair and anti-aging, yet its heterologous expression often faces challenges such as incomplete structure and poor thermostability. Here, we established a transgenic zebrafish expression system via CRISPR/Cas9 technology, integrating the human Col3a1 gene into a non-functional region of zebrafish chromosome 4. The extraction yield of total zebrafish collagen (Col III-TC), a composite material comprising both recombinant human Col III and endogenous zebrafish collagens, was 45.76%. Structural analysis revealed intact fibrous architecture and a thermal shrinkage temperature of 71.3 °C, significantly superior to conventional systems.
2. Nontarget screening and suspect identification of organic chlorinated compounds in cosmetics and personal care products using UHPLC-Q-Orbitrap-HRMS.
An integrated UHPLC-Q-Orbitrap-HRMS workflow identified 227 organic chlorinated compounds in children’s skincare products, including banned chemicals such as triclosan, elubiol, and 4-chloroaniline. Chlorhexidine was quantified up to 0.456%, and higher-confidence identifications were enriched for heterocyclics and ethers, underscoring the need for tighter regulation and transparent labeling.
Impact: This study provides a robust, scalable surveillance framework that uncovered banned and potentially hazardous chlorinated chemicals in children’s skincare products, directly informing regulatory and public health actions.
Clinical Implications: Dermatologists and pediatricians should be aware of potential irritants and sensitizers in pediatric skincare; findings support stricter screening, post-market surveillance, and guidance for sensitive-skin patients.
Key Findings
- A total of 227 chlorinated compounds were tentatively identified (3 CL1, 9 CL2, 93 CL3, 122 CL4) across children’s skincare products.
- Heterocyclics and ethers predominated among higher-confidence (CL1–CL3) identifications.
- Chlorhexidine was quantified up to 0.456% in certain products.
- Banned chemicals (triclosan, elubiol, 4-chloroaniline) were detected in at least one product.
Methodological Strengths
- Isotope-pattern-based nontarget screening combined with suspect identification in high-resolution Orbitrap MS
- Applied validation in real-world children’s skincare products with quantitative confirmation for selected analytes
Limitations
- Many identifications are tentative (CL3–CL4), lacking confirmatory standards for all compounds
- Study focused on products sold in China; exposure assessment and health risk quantification were not performed
Future Directions: Expand surveillance to other regions and product categories, confirm identities with reference standards, quantify broader panels, and integrate biomonitoring/risk assessment to link product content with human exposure.
Organic chlorinated compounds have been extensively incorporated into cosmetics and personal care products (CPCPs) as germicides, surfactants, and oil-controlling agents, leading to potential human exposure and associated health risks. However, available research has mostly been limited to several chlorinated compounds in CPCPs, e.g., triclosan and triclocarban. In this study, an integrated analytical framework was established combining isotope-pattern-based nontarget screening with database-assisted suspect identification to comprehensively characterize organic chlorinated compounds in CPCPs.
3. Modulation of Mast Cell Activation via MRGPRX2 by Natural Oat Extract.
Oat kernel extract significantly inhibited MRGPRX2-mediated mast cell degranulation triggered by c48/80, substance P, and cortistatin 14 without affecting cell viability. Effects were confirmed across multiple readouts and in primary human mast cells, revealing a previously unrecognized mechanism for natural anti-itch/anti-inflammatory action.
Impact: First demonstration that an oat extract can suppress MRGPRX2 signaling provides a mechanistic basis for itch relief by natural ingredients and a new target pathway for cosmeceutical development.
Clinical Implications: Supports development of topical formulations for pruritus and sensitive skin leveraging MRGPRX2 inhibition; however, in vivo efficacy, allergenicity, and standardization of active components are needed before clinical recommendations.
Key Findings
- Oat extract significantly reduced degranulation triggered by three MRGPRX2 ligands (c48/80, substance P, cortistatin 14).
- Inhibition was confirmed by decreased β-hexosaminidase and tryptase release, reduced CD63/CD107a expression, and lowered ERK phosphorylation.
- Cell viability was unaffected, and results were replicated in primary human mast cells.
Methodological Strengths
- Multiple orthogonal degranulation readouts and signaling assays
- Validation in both a human mast cell line (LAD2) and primary human mast cells
Limitations
- No in vivo or clinical data to confirm efficacy on pruritus/inflammation
- Active constituents and batch-to-batch variability of the extract were not resolved
Future Directions: Isolate and characterize active molecules, assess topical pharmacokinetics and safety, and test efficacy in animal models of pruritus/dermatitis followed by early clinical trials.
The Mas-related G protein-coupled receptor (MRGPR) X2 is expressed on skin mast cells and can be stimulated by an unusually broad spectrum of ligands, including specific drugs and even endogenous peptides. MRGPRX2 activation can induce mast cell degranulation and consequently mediator release, leading to inflammatory and hypersensitivity reactions. In addition, MRGPRX2 mediates pain and itching sensations, leading to increased efforts to identify MRGPRX2 inhibitors, including plant-derived compounds. Components within oat extracts have been shown to mediate anti-inflammatory and itch-relieving properties, but a possible inhibitory effect on MRGPRX2 activation has not yet been investigated. We aimed to fill this gap and explored whether an oat kernel extract can modulate MRGPRX2 activation. For this purpose, we established a mast cell model with the human LAD2 cell line and used it to investigate the consequences of exposure to oat extract. While we did not observe any influence on cell viability, we analyzed the impact of oat extract on MRGPRX2-mediated mast cell activation and degranulation initiated by the three confirmed MRGPRX2 ligands c48/80, substance P, and cortistatin 14. Exposure to oat extract resulted in a significant reduction in mast cell degranulation for all three ligands, as assessed by the release of β-hexosaminidase, tryptase, cell surface expression of CD63 and CD107a, and phosphorylation of ERK.